Home/Filings/4/0001127602-23-026977
4//SEC Filing

Khosla Rachna 4

Accession 0001127602-23-026977

CIK 0000318154other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 8:16 PM ET

Size

6.9 KB

Accession

0001127602-23-026977

Insider Transaction Report

Form 4
Period: 2023-11-05
Khosla Rachna
SVP, Business Development
Transactions
  • Tax Payment

    Common Stock

    2023-11-05$269.86/sh173$46,6867,467 total
  • Tax Payment

    Common Stock

    2023-11-05$269.86/sh144$38,8607,323 total
Footnotes (2)
  • [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 102 RSUs which will vest on 5/5/2024; 252 RSUs which will vest in installments of 124 on 4/30/2024 and 128 on 4/30/2025; 784 RSUs which will vest in installments of 386 on 11/5/2024 and 398 on 11/5/2025; 606 RSUs which will vest in installments of 199 on 5/2/2024, 200 on 5/2/2025, and 207 on 5/2/2026; and 593 RSUs which will vest in in installments of 195 on 5/2/2025, 196 on 5/2/2026 and one installment of 202 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include 130 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001881332

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 8:16 PM ET
Size
6.9 KB